Pacira BioSciences (PCRX) Price to FCF (2011 - 2026)

Pacira BioSciences has reported Price to FCF for 16 years, with the latest figure at 18.0 in Q2 2026.

• On a quarterly basis, Price to FCF fell 84.37% year-over-year to 18.0 in Q2 2026; TTM through Jun 2026 was 5.63, a 38.6% decrease from a year earlier, with the FY2025 full-year figure at 7.79, up 59.77% from the prior year.
• Price to FCF was 18.0 for Q2 2026 at Pacira BioSciences, down from 38.7 in the prior quarter.
• The five-year high for Price to FCF was 149.33 in Q1 2023, with the low at 13.94 in Q3 2024.
• Average Price to FCF over 5 years is 57.24, with a median of 36.7 recorded in 2026.
• The sharpest annual moves came in 2025 and 2026: Price to FCF jumped 350.91% in 2025, then plunged 84.37% in 2026.
• Over 5 years, Price to FCF stood at 48.52 in 2022, then slipped by 29.41% to 34.25 in 2023, then decreased by 17.99% to 28.09 in 2024, then declined by 12.86% to 24.48 in 2025, then retreated by 26.46% to 18.0 in 2026.
• The last three Price to FCF figures came in at 18.0 (Q2 2026), 38.7 (Q1 2026), and 24.48 (Q4 2025), per Business Quant data.